Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr Lal Pathlabs has informed about the Financial Results Conference Call Transcript of the Company for Q3 9M FY18.
The above information is a part of company’s filings submitted to BSE.